Zydus Lifesciences Limited has informed the Exchange about change in Management
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Zydus Lifesciences has approved the re-appointment of Mr. Ganesh N. Nayak as a Director in employment for a further period of 5 years, from July 12, 2025 to July 11, 2030. Mr. Nayak, who has been with the Zydus Group since 1977 and has over 48 years of experience spearheading the group's business, will cease to be a Key Managerial Personnel (KMP) with effect from the close of business hours on July 11, 2025. He will receive a fixed remuneration of Rs. 3 million per month (Rs. 36 million per annum), subject to annual revision based on individual and company performance. The re-appointment is subject to shareholder approval by special resolution at the upcoming Annual General Meeting.
This signals continuity and stability in Zydus's senior leadership, as a long-tenured executive continues on the board. The transition from KMP to non-KMP director status is a structural change rather than a departure, and is unlikely to materially affect stock price or shareholder interests in the near term.